Katherine J Bangen1, Alexandra J Weigand1, Kelsey R Thomas2, Lisa Delano-Wood3, Lindsay R Clark4, Joel Eppig5, Madeleine L Werhane5, Emily C Edmonds6, Mark W Bondi3. 1. Weigand Research Service, Veterans Affairs San Diego Healthcare System. 2. Research Service and Psychology Service, Veterans Affairs San Diego Healthcare System. 3. Psychology Service, Veterans Affairs San Diego Healthcare System. 4. Wisconsin Alzheimer's Institute, University of Wisconsin School of Medicine. 5. San Diego Joint Doctoral Program in Clinical Psychology, San Diego State University/University of California, San Diego. 6. Research Service, Veterans Affairs San Diego Healthcare System.
Abstract
OBJECTIVE: Intraindividual cognitive variability (IIV), a measure of within-person variability across cognitive measures at a single time point, is associated with mild cognitive impairment (MCI) and Alzheimer's disease (AD). Little is known regarding brain changes underlying IIV, or the relationship between IIV and functional ability. Therefore, we investigated the association between IIV and cerebral atrophy in AD-vulnerable regions and everyday functioning in nondemented older adults. METHOD: 736 Alzheimer's Disease Neuroimaging Initiative (ADNI) participants (285 cognitively normal [CN]; 451 MCI) underwent neuropsychological testing and serial MRI over 2 years. Linear mixed effects models examined the association between baseline IIV and change in entorhinal cortex thickness, hippocampal volume, and everyday functioning. RESULTS: Adjusting for age, sex, apolipoprotein E genotype, amyloid-β positivity, and mean level of cognitive performance, higher baseline IIV predicted faster rates of entorhinal and hippocampal atrophy, as well as functional decline. Higher IIV was associated with both entorhinal and hippocampal atrophy among MCI participants but selective vulnerability of the entorhinal cortex among CN individuals. CONCLUSIONS: IIV was associated with more widespread medial temporal lobe (MTL) atrophy in individuals with MCI relative to CN, suggesting that IIV may be tracking advancing MTL pathologic changes across the continuum of aging, MCI, and dementia. Findings suggest that cognitive dispersion may be a sensitive marker of neurodegeneration and functional decline in nondemented older adults. (PsycINFO Database Record (c) 2019 APA, all rights reserved).
OBJECTIVE: Intraindividual cognitive variability (IIV), a measure of within-person variability across cognitive measures at a single time point, is associated with mild cognitive impairment (MCI) and Alzheimer's disease (AD). Little is known regarding brain changes underlying IIV, or the relationship between IIV and functional ability. Therefore, we investigated the association between IIV and cerebral atrophy in AD-vulnerable regions and everyday functioning in nondemented older adults. METHOD: 736 Alzheimer's Disease Neuroimaging Initiative (ADNI) participants (285 cognitively normal [CN]; 451 MCI) underwent neuropsychological testing and serial MRI over 2 years. Linear mixed effects models examined the association between baseline IIV and change in entorhinal cortex thickness, hippocampal volume, and everyday functioning. RESULTS: Adjusting for age, sex, apolipoprotein E genotype, amyloid-β positivity, and mean level of cognitive performance, higher baseline IIV predicted faster rates of entorhinal and hippocampal atrophy, as well as functional decline. Higher IIV was associated with both entorhinal and hippocampal atrophy among MCI participants but selective vulnerability of the entorhinal cortex among CN individuals. CONCLUSIONS: IIV was associated with more widespread medial temporal lobe (MTL) atrophy in individuals with MCI relative to CN, suggesting that IIV may be tracking advancing MTL pathologic changes across the continuum of aging, MCI, and dementia. Findings suggest that cognitive dispersion may be a sensitive marker of neurodegeneration and functional decline in nondemented older adults. (PsycINFO Database Record (c) 2019 APA, all rights reserved).
Authors: Bruce Fischl; André van der Kouwe; Christophe Destrieux; Eric Halgren; Florent Ségonne; David H Salat; Evelina Busa; Larry J Seidman; Jill Goldstein; David Kennedy; Verne Caviness; Nikos Makris; Bruce Rosen; Anders M Dale Journal: Cereb Cortex Date: 2004-01 Impact factor: 5.357
Authors: Susan M Landau; Christopher Breault; Abhinay D Joshi; Michael Pontecorvo; Chester A Mathis; William J Jagust; Mark A Mintun Journal: J Nucl Med Date: 2012-11-19 Impact factor: 10.057
Authors: Rebecca L Koscik; Sara E Berman; Lindsay R Clark; Kimberly D Mueller; Ozioma C Okonkwo; Carey E Gleason; Bruce P Hermann; Mark A Sager; Sterling C Johnson Journal: J Int Neuropsychol Soc Date: 2016-11 Impact factor: 2.892
Authors: R C Petersen; P S Aisen; L A Beckett; M C Donohue; A C Gamst; D J Harvey; C R Jack; W J Jagust; L M Shaw; A W Toga; J Q Trojanowski; M W Weiner Journal: Neurology Date: 2009-12-30 Impact factor: 9.910
Authors: Tomiko Yoneda; Alejandra Marroig; Eileen K Graham; Emily C Willroth; Tamlyn Watermeyer; Emorie D Beck; Elizabeth M Zelinski; Chandra A Reynolds; Nancy L Pedersen; Scott M Hofer; Daniel K Mroczek; Graciela Muniz-Terrera Journal: Neuropsychology Date: 2021-11-22 Impact factor: 3.295
Authors: Katherine J Bangen; Kelsey R Thomas; Alexandra J Weigand; Danielle L Sanchez; Lisa Delano-Wood; Emily C Edmonds; Owen T Carmichael; Christopher G Schwarz; Adam M Brickman; Mark W Bondi Journal: Neurobiol Aging Date: 2019-11-02 Impact factor: 4.673
Authors: Dallas P Veitch; Michael W Weiner; Paul S Aisen; Laurel A Beckett; Charles DeCarli; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; Susan M Landau; John C Morris; Ozioma Okonkwo; Richard J Perrin; Ronald C Petersen; Monica Rivera-Mindt; Andrew J Saykin; Leslie M Shaw; Arthur W Toga; Duygu Tosun; John Q Trojanowski Journal: Alzheimers Dement Date: 2021-09-28 Impact factor: 16.655
Authors: Scott F Sorg; Victoria C Merritt; Alexandra L Clark; Madeleine L Werhane; Kelsey A Holiday; Dawn M Schiehser; Mark Bondi; Lisa Delano-Wood Journal: J Int Neuropsychol Soc Date: 2020-09-24 Impact factor: 2.892
Authors: Kelsey R Thomas; Katherine J Bangen; Alexandra J Weigand; Emily C Edmonds; Christina G Wong; Shanna Cooper; Lisa Delano-Wood; Mark W Bondi Journal: Neurology Date: 2019-12-30 Impact factor: 11.800
Authors: Danielle L Sanchez; Kelsey R Thomas; Emily C Edmonds; Mark W Bondi; Katherine J Bangen Journal: J Alzheimers Dis Date: 2020 Impact factor: 4.160